Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahito Ohji

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 31, 2024
Submacular hemorrhage: My personal journey to the goalMasahito Ohji
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 11, 2016
Unexpected complications related to tamponade after vitrectomyMasahito Ohji
Nippon Ganka Gakkai Zasshi|April 15, 2005
[Current topics in vitreoretinal diseases]Masahito Ohji
Japanese Journal of Ophthalmology|July 16, 2008
Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): results of the Japanese AMD Trial (JAT) extension, Masahito Ohji
Acta Ophthalmologica|January 15, 2011
Long-term efficacy and safety of ranibizumab administered pro re nata in Japanese patients with neovascular age-related macular degeneration in the EXTEND-I studyYasuo Tano, Masahito Ohji,
Clinical Ophthalmology (Auckland, N.Z.)|December 21, 2018
Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathyTomoaki Higashiyama, Masahito Ohji
Acta Ophthalmologica|February 19, 2010
EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationYasuo Tano, Masahito Ohji,
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 7, 2014
Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degenerationTomoko Sawada, Masahito Ohji
Japanese Journal of Ophthalmology|August 12, 2010
Spontaneous closure of a macular hole after vitrectomy for an epiretinal membraneMigiwa Ogawa, Masahito Ohji
Retina (Philadelphia, Pa.)|June 10, 2015
Reply: To PMID 25062437Masato Fujikawa, Masahito Ohji
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 31, 2024
Submacular hemorrhage: My personal journey to the goalMasahito Ohji
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 11, 2016
Unexpected complications related to tamponade after vitrectomyMasahito Ohji
Nippon Ganka Gakkai Zasshi|April 15, 2005
[Current topics in vitreoretinal diseases]Masahito Ohji
Japanese Journal of Ophthalmology|July 16, 2008
Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): results of the Japanese AMD Trial (JAT) extension, Masahito Ohji
Acta Ophthalmologica|January 15, 2011
Long-term efficacy and safety of ranibizumab administered pro re nata in Japanese patients with neovascular age-related macular degeneration in the EXTEND-I studyYasuo Tano, Masahito Ohji,
Clinical Ophthalmology (Auckland, N.Z.)|December 21, 2018
Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathyTomoaki Higashiyama, Masahito Ohji
Acta Ophthalmologica|February 19, 2010
EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degenerationYasuo Tano, Masahito Ohji,
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 7, 2014
Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degenerationTomoko Sawada, Masahito Ohji
Japanese Journal of Ophthalmology|August 12, 2010
Spontaneous closure of a macular hole after vitrectomy for an epiretinal membraneMigiwa Ogawa, Masahito Ohji
Retina (Philadelphia, Pa.)|June 10, 2015
Reply: To PMID 25062437Masato Fujikawa, Masahito Ohji
Pageof 20